Metformin Enhances Anti-proliferative Effect of Cisplatin in Cervical Cancer Cell Line

Journal Title: Indonesian Journal of Clinical Pharmacy - Year 2016, Vol 5, Issue 2

Abstract

Cervival cancer is one of the top rank of gynecological malignancy in the world, leading to high morbidity and mortality rates. Cisplatin is a chemotherapeutic agent that is generally used to treat cervical cancer but the use of this drug is limited because of serious side effects. Metformin, a diabetic drug, decreases not only blood glucose levels but also cell viability of some cancer cells. The aim of this study was to investigate the anti-proliferative effect of combination metformin and cisplatin in HeLa cells (cervical cancer cell line). Anti-proliferative effect of these combined drugs was analized using MTT assay, combination index assay and HeLa cell morphology. Inhibitory concentration (IC50) of cisplatin and metformin was determined before performing combination index assay. Administration of 10 mM metformin showed inhibition of HeLa cell proliferation and it reached 50% inhibition of cell proliferation at 60 mM. Whilst, cisplatin showed a stronger anti-proliferative effect with initial inhibition dose at 12 µM and IC50 dose at 44 µM. Combination of 30 mM metformin and 5 µM cisplatin indicated the strongest anti-proliferative effect on HeLa cell. In conclusion, metformin may become a promising drug for treatment of cervical cancer in future which enhances anti-proliferative effect of cisplatin.

Authors and Affiliations

Ratih D. Yudhani, Riza N. Pesik, Dono Indarto

Keywords

Related Articles

Validation of Indonesian Version of FACIT Fatigue Scale Questionnaire in Chronic Kidney Disease (CKD) Patients with Routine Hemodialysis

Anemia is common in Chronic Kidney Disease (CKD). One of anemia consequences is fatigue which can lead to decrease in quality of life. Functional Assessment Chronic Illness Therapy (FACIT) Fatigue Scale is an instrument...

Ocular Insert: Dosage Form for Sustain Opthalmic Drug Delivery

Except for skin, the eye is the most easily accessible site for topical administration of a medication. Traditional topical ophthalmic formulations (eye drops and ointments) have poor bioavailability because of rapid pre...

Prevention of Cardiovascular Disease in Diabetes Mellitus Outpatient: Focusing on Antiplatelet, Statins and Irrational Antihypertensive Drug Use

Cardiovascular disease complication is a major cause of morbidity and mortality in diabetes mellitus (DM) patients and all at once is an addition to economic burden to both the patient and government in the era of univer...

Cost-effectiveness Analysis of Antipsychotic Combination Therapy in Schizophrenia Inpatients

Schizophrenia is one of mental disorders with high cost and lifetime morbidity risk. Hence, it is necessary to analyze the cost-effectiveness of various combinations of antipsychotics. The aim of this study was to analyz...

Role of Leadership and Employee Engagement towards Individual Performance of Pharmacy Employees

Employees dissatisfaction to the head of the hospital pharmacy will decrease employees performance and unsatisfied customers. To solve the problems, employees should be based on performance as customer expectations in pr...

Download PDF file
  • EP ID EP365266
  • DOI 10.15416/ijcp.2016.5.2.75
  • Views 85
  • Downloads 0

How To Cite

Ratih D. Yudhani, Riza N. Pesik, Dono Indarto (2016). Metformin Enhances Anti-proliferative Effect of Cisplatin in Cervical Cancer Cell Line. Indonesian Journal of Clinical Pharmacy, 5(2), 75-83. https://europub.co.uk/articles/-A-365266